Member Login
  1. Stocks
    2. /
  2. Canopy Growth (TSX: WEED)
    3. /

TSX:WEED (Canopy Growth)

About WEED

Canopy Growth Corp. engages in the production and sale of medical cannabis. The firm operates through the following segments: Global Cannabis and Other Consumer Products. The Global Cannabis segment encompasses the production, distribution and sale of a diverse range of cannabis and cannabinoid-based consumer products in Canada and internationally pursuant to applicable international and domestic legislation, regulations and permits. The Other Consumer Products segment encompasses the production, distribution and sale of consumer products by Storz & Bickel, This Works, BioSteel, and other ancillary revenue sources. It focuses on the treatment of chronic pain, seizures, muscle spasms, nausea, and loss of appetite. The company was founded by Bruce Linton on August 5, 2009 and is headquartered in Smith Falls, Canada.
Financial Market Data copyright © 2024 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

    • Canopy Growth (TSX: WEED) Latest News

    Investing

    4 Cheap Canadian Stocks That Could Deliver Superior Returns in 2022

    | Rajiv Nanjapla

    Given their healthy growth potential and discounted stock prices, I expect these four cheap Canadian stocks to outperform this year.

    Read more »

    Cannabis Stocks

    Why Canopy Growth Stock Plunged 66% in 2021

    | Amy Legate-Wolfe

    Canopy Growth (TSX:WEED)(NYSE:CGC) had a horrible year, losing 66% of its value. But should Motley Fool investors see it as…

    Read more »

    Investing

    Is BlackBerry (TSX:BB) Stock or Canopy Growth (TSX:WEED) Stock a Buy in January?

    | Andrew Walker

    BlackBerry and Canopy Growth had a rough ride in the back half of 2021.

    Read more »

    Cannabis Stocks

    Why Canopy Growth Stock Fell 20% in December

    | Aditya Raghunath

    Here's why Canopy Growth (TSX:WEED) stock is a high-risk bet for 2022.

    Read more »

    Cannabis Stocks

    These 5 Cannabis Stocks Are High-Risk Holdings Like Bitcoin

    | Christopher Liew, CFA

    Bitcoin is highly volatile but unlike the top cannabis stocks, the crypto delivered gains to investors in 2021.

    Read more »

    Investing

    2 Unloved 2021 Stocks That Could Soar in 2022

    | Andrew Walker

    These two stocks carry risks, but could deliver big gains for contrarian investors in 2022.

    Read more »

    Cannabis Stocks

    Why Is Canopy Growth Stock up 8% in the Last Week?

    | Aditya Raghunath

    Canopy Growth stock remains a high-risk bet, despite its 60% decline in 2022.

    Read more »

    Investing

    Late Christmas Gift: Why Stocks Could Soar in January

    | Andrew Button

    Investors who sold Canopy Growth Corp (TSX:WEED)(NYSE:CGC) might be tax-loss harvesting. If that's the case, they could be back into…

    Read more »

    Investing

    Down Over 10% in December: Should You Buy These 3 Canadian Stocks?

    | Rajiv Nanjapla

    Given their healthy growth prospects and a significant discount on their stock prices, these three Canadian stocks could deliver superior…

    Read more »

    Cannabis Stocks

    2 Dirt-Cheap Cannabis Stocks That Could Soar in 2022

    | Ambrose O'Callaghan

    Cannabis stocks like Canopy Growth Corp. (TSX:WEED)(NYSE:CGC) and Tilray Inc. (TSX:TLRY)(NASDAQ:TLRY) still hold nice growth potential.

    Read more »

    Investing

    4 High-Growth TSX Stocks That Dropped on Monday: Should You Buy?

    | Vineet Kulkarni

    Apart from the fears of the new variant, rising inflation and upcoming tightening monetary policy also weighed on stocks.

    Read more »

    Cannabis Stocks

    Canopy Growth (TSX:WEED) Falls 11% and Hits 52-Week Low

    | Amy Legate-Wolfe

    Canopy Growth (TSX:WEED)(NYSE:CGC) saw shares continue to drop on Dec. 20, falling by 11% to hit a share price not…

    Read more »